ProofPilot to Integrate Lilly's Magnol.AI™ Sensor Cloud Into its Clinical Trial Automation Platform
ProofPilot has announced a strategic collaboration with Eli Lilly and Company (Lilly) to offer Lilly's patent-pending, sensor cloud platform, Magnol.AI™, a platform that enables management of high-frequency sensor data with security, as part of ProofPilot's technology solution.
For the first time, Lilly is out-licensing its technology. This technology-focused collaboration with Lilly and ProofPilot will enable both companies to help the broader research community to execute digital health research, helping to accelerate pre-competitive biomedical research.
"We are thrilled to collaborate with Lilly and leverage its industry-leading sensor cloud, further strengthening our commitment to provide our customers with the most advanced solutions and enable flawless execution of clinical research" said Chris Venezia, CEO of ProofPilot in a press release. "By integrating Magnol.AI™ into our platform, researchers finally have a one-stop, comprehensive solution to execute digital health research and deliver sensor data-driven insight with the highest quality."
Magnol.AI™ is Lilly's sensor cloud platform that allows for ingestion, visualization, and extraction of high-frequency sensor data with security. It is able to ingest and align a wide array of raw data from wearables, devices, and beyond in a clear time-series format. When aligned with clinician and patient reported outcomes, Magnol.AI™ enables real-time data science capabilities for digital health and digital biomarker research.
ProofPilot's mission is to perfect clinical research execution by orchestrating technology, tasks, content, and communication through its clinical trial automation platform. When combined with Lilly's sensor cloud Magnol.AI™, ProofPilot delivers a data science solution to digital health and digital biomarker researchers around the world. With this new integration, any researcher can now have access to a digital health research platform that combines data collection, sensor ingestion, device management, and participant engagement.
Reference
ProofPilot To Integrate Lilly's Magnol.AI™ Sensor Cloud Into Its Clinical Trial Automation Platform. (2023, September 28). Cision PR Newswire.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
